Wolverine Trading, LLC Revance Therapeutics, Inc. Put Options Transaction History

Wolverine Trading, LLC

14 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$4.65 - $9.31 $51,615 - $103,341	11,100 New	11,100 $54,000
Q3 2023 Nov 15, 2023	SELL	$11.47 - $25.07 $88,319 - $193,039	-7,700 Reduced 23.26%	25,400 $291,000
Q2 2023 Aug 23, 2023	SELL	$24.7 - $37.61 $9,880 - $15,044	-400 Reduced 1.19%	33,100 $837,000
Q1 2023 May 15, 2023	SELL	$18.36 - $35.27 $137,700 - $264,525	-7,500 Reduced 18.29%	33,500 $1.04 Million
Q4 2022 Feb 14, 2023	BUY	$18.32 - $30.66 $109,920 - $183,960	6,000 Added 17.14%	41,000 $757,000
Q3 2022 Nov 14, 2022	BUY	$14.33 - $28.47 $501,550 - $996,450	35,000 New	35,000 $898,000
Q4 2019 Feb 12, 2020	SELL	$11.66 - $20.15 $15,158 - $26,194	-1,300 Reduced 7.56%	15,900 $256,000
Q3 2019 Nov 14, 2019	SELL	$10.22 - $14.5 $41,902 - $59,450	-4,100 Reduced 19.25%	17,200 $237,000
Q2 2019 Aug 20, 2019	BUY	$10.67 - $15.49 $101,365 - $147,155	9,500 Added 80.51%	21,300 $276,000
Q1 2019 May 15, 2019	SELL	$15.4 - $20.39 $10,780 - $14,273	-700 Reduced 5.6%	11,800 $186,000
Q4 2018 Feb 14, 2019	SELL	$18.06 - $24.96 $95,718 - $132,288	-5,300 Reduced 29.78%	12,500 $243,000
Q3 2018 Nov 14, 2018	BUY	$23.55 - $30.1 $162,495 - $207,690	6,900 Added 63.3%	17,800 $442,000
Q1 2018 May 15, 2018	SELL	$29.15 - $37.4 $116,600 - $149,600	-4,000 Reduced 26.85%	10,900 $336,000
Q4 2017 Feb 14, 2018	BUY	$24.55 - $36.3 $365,795 - $540,870	14,900	14,900 $533,000

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.